PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALZN vs. SAVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


ALZNSAVA
YTD Return14.61%-9.28%
1Y Return-84.37%-12.96%
Sharpe Ratio-0.91-0.21
Daily Std Dev93.56%72.48%
Max Drawdown-99.60%-99.18%
Current Drawdown-99.50%-84.91%

Fundamentals


ALZNSAVA
Market Cap$7.08M$856.29M
EPS-$2.28-$2.32
PEG Ratio1.1720.44
Revenue (TTM)$0.00$0.00
Gross Profit (TTM)$0.00-$68.03M
EBITDA (TTM)-$15.12M-$104.43M

Correlation

0.18
-1.001.00

The correlation between ALZN and SAVA is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ALZN vs. SAVA - Performance Comparison

In the year-to-date period, ALZN achieves a 14.61% return, which is significantly higher than SAVA's -9.28% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%-90.00%-80.00%-70.00%-60.00%OctoberNovemberDecember2024FebruaryMarch
-99.50%
-71.68%
ALZN
SAVA

Compare stocks, funds, or ETFs


Alzamend Neuro, Inc.

Cassava Sciences, Inc.

Risk-Adjusted Performance

ALZN vs. SAVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alzamend Neuro, Inc. (ALZN) and Cassava Sciences, Inc. (SAVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ALZN
Alzamend Neuro, Inc.
-0.91
SAVA
Cassava Sciences, Inc.
-0.21

ALZN vs. SAVA - Sharpe Ratio Comparison

The current ALZN Sharpe Ratio is -0.91, which is lower than the SAVA Sharpe Ratio of -0.21. The chart below compares the 12-month rolling Sharpe Ratio of ALZN and SAVA.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.00OctoberNovemberDecember2024FebruaryMarch
-0.91
-0.21
ALZN
SAVA

Dividends

ALZN vs. SAVA - Dividend Comparison

Neither ALZN nor SAVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALZN vs. SAVA - Drawdown Comparison

The maximum ALZN drawdown since its inception was -99.60%, roughly equal to the maximum SAVA drawdown of -99.18%. The drawdown chart below compares losses from any high point along the way for ALZN and SAVA


-100.00%-95.00%-90.00%-85.00%-80.00%OctoberNovemberDecember2024FebruaryMarch
-99.50%
-84.91%
ALZN
SAVA

Volatility

ALZN vs. SAVA - Volatility Comparison

Alzamend Neuro, Inc. (ALZN) has a higher volatility of 30.11% compared to Cassava Sciences, Inc. (SAVA) at 18.80%. This indicates that ALZN's price experiences larger fluctuations and is considered to be riskier than SAVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%OctoberNovemberDecember2024FebruaryMarch
30.11%
18.80%
ALZN
SAVA